CareDx Inc. announced the launch of AlloHome, a pan-organ patient monitoring tool located on the AlloCare app that can capture health data from the comfort of a patient’s home, according to a press release.
Patients who use AlloHome receive Bluetooth devices, including a glucose monitor and a blood pressure cuff, that automatically pair with a smart hub in the house. Data also pair with the patient’s AlloCare app. Read the full story in Healio.
AUGUST, 02, 2022
AlloHome Alerts Healthcare Provider of Adverse Events to Drive Earlier Interventions
BRISBANE, Calif.–(BUSINESS WIRE)– CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced the availability of AlloHome™, a pan-organ patient monitoring solution that extends care into a patient’s home by capturing a range of vital health data that can help doctors with the early identification of adverse clinical events and the ability to make preemptive measures to avoid complications pre- and post-transplantation.
Read the full press release at CareDx.com.